Linkedin
SCIRENT: Advancing cardiovascular research for a healthier tomorrow
Get in touch

Clinical Phases

From early‑phase studies to market approval, SCIRENT helps clients move forward with speed and precision. We support biopharmaceutical and medical device innovators at every step of clinical development, combining deep scientific expertise with tailored solutions to help bring new treatments to patients faster.

Phase I – First-in-Human, Focused on Safety

SCIRENT conducts Phase I cardiovascular trials with a focus on safety, tolerability, and pharmacokinetics in a controlled clinical setting.

Phase IIa – Proof of Concept & Dose-Finding in Target Populations

SCIRENT supports Phase IIa cardiovascular trials to identify early efficacy signals and optimal dose ranges in target patient populations.

Phase IIb – Confirmatory Efficacy and Safety

Explore how SCIRENT designs and manages Phase IIb cardiovascular trials to validate efficacy, ensure safety, and refine trial parameters ahead of large-scale Phase III studies.

Phase III – Pivotal Trials at Scale

SCIRENT manages large-scale Phase III cardiovascular trials to demonstrate safety and efficacy across diverse patient populations and geographies.

Phase IV – Real-World Evidence and Post-Market Insights

SCIRENT conducts Phase IV studies to generate real-world evidence on long-term safety, effectiveness, and clinical adoption in cardiovascular care.

Get in touch with us.

How can we help you? We will get in touch shortly.

European Clinical Trial Experts: Advancing Medical Research and Innovation
Clinical Research
and Science
Main Menu
Segments
Cardiovascular Indications
Services
Clinical Phases
Get in touch

Thank you. Your data was submitted successfully.

We will get in touch shortly.

Book a meeting

Thank you for your application.

We will get in touch shortly.